Abstract:Iron is a fundamental metal involved in many cellular and biological processes in all organisms, humans included. Iron homeostasis is finely regulated both systemically and at the level of the Central Nervous System (CNS) to avoid its imbalance; indeed, iron excess is extremely toxic for cells and triggers detrimental oxidative stress increase. Nevertheless, factors such as genetics, environment, and aging can alter the normal iron metabolism leading to diseases, including neurodegenerative disorders such as Alzheimer's disease (AD). AD is the most widespread neurodegenerative disorder of the CNS. Although the precise pathogenesis of AD is not clarified yet, different studies conducted both in mouse models and in patients reported brain iron accumulation, resulting in cognitive, memory, and motor decline. Moreover, the expression of many proteins involved in iron metabolism appears to be altered in the brain, leading to iron deposition and promoting AD progression. In the context of AD, amyloid beta (Aβ) and tau hyperphosphorylation, the two hallmarks of the disease, can promote brain iron deposition and subsequent neuronal death. Indeed, although the mechanism of neuronal loss is not fully understood, several evidence demonstrated the involvement of the iron-dependent form of cell death defined as "ferroptosis". In this review, we deepened about the role of iron and iron deregulation in the CNS with a particular focus on its involvement in the pathogenesis of AD. We also discussed the potential role of ferroptosis as a new pathological mechanism related to dementia. Finally, we reviewed recent strategies for treating AD based on the use of iron chelators, antioxidants and ferroptosis inhibitors, paying close attention to iron disorders and the development of new drugs capable of preventing AD.

Iron Homeostasis and Neurodegeneration in the Aging Brain: Insight into Ferroptosis Pathways

Insight into the Role of Ferroptosis in Non-neoplastic Neurological Diseases

Implication of Ferroptosis in Aging

Brain Iron Dyshomeostasis and Ferroptosis in Alzheimer's Disease Pathophysiology: Two Faces of the Same Coin

Targeting ferroptosis as a potential prevention and treatment strategy for aging-related diseases

Ferroptosis: A potential therapeutic target for neurodegenerative diseases

Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease

Nrf2 and Ferroptosis: Exploring Translational Avenues for Therapeutic Approaches to Neurological Diseases

Understanding the Mechanism of Ferroptosis in Neurodegenerative Diseases

Iron Dyshomeostasis and Ferroptosis: A New Alzheimer’s Disease Hypothesis?

Iron and Ferroptosis More than a Suspect: Beyond the Most Common Mechanisms of Neurodegeneration for New Therapeutic Approaches to Cognitive Decline and Dementia

Research on Ferroptosis as a Therapeutic Target for the Treatment of Neurodegenerative Diseases

Considerations for Using Neuroblastoma Cell Lines to Examine the Roles of Iron and Ferroptosis in Neurodegeneration

Cellular Senescence and Iron Dyshomeostasis in Alzheimer’s Disease

Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases

The Aging of Iron Man

A critical appraisal of ferroptosis in Alzheimer's and Parkinson's disease: new insights into emerging mechanisms and therapeutic targets

Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases

Iron Dysregulation in Mitochondrial Dysfunction and Alzheimer’s Disease

Iron homeostasis imbalance and ferroptosis in brain diseases

Ferroptosis, a Potential Therapeutic Target in Alzheimer’s Disease